KPTI- Karyopharm Therapeutics Inc.

Name: Karyopharm Therapeutics Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Paulson Richard A.	198.3K	$1.78M	-
VP	Cheng Sohanya Roshan	79.5K	$715.6K	-
VP	Poulton Stuart	67.4K	$606.5K	-
VP	Mano Michael	65.1K	$585.7K	-
VP	Rangwala Reshma	56.3K	$506.6K	-

Activity

Buys and sells only

Transactions

10 filings · page 12

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 18, 2021	Shacham Sharon79	President &CSO	Sell	4,000	$12.39	$49,552.80	-0.6%	-16.7%	-40.4%
Mar 18, 2021	Kauffman Michael78	Chief Executive Officer	Sell	4,000	$12.39	$49,552.80	-0.6%	-16.7%	-40.4%
Feb 18, 2021	Shah Jatin54	EVP, Chief Medical Officer	Sell	1,186	$14.83	$17,589.80	-2.2%	-	-
Feb 18, 2021	Shacham Sharon79	President &CSO	Sell	18,990	$14.83	$281,644.49	-1.4%	-	-
Feb 18, 2021	Kauffman Michael78	Chief Executive Officer	Sell	18,990	$14.83	$281,644.49	-1.4%	-	-
Feb 18, 2021	Frenkel Ran78	EVP, Chief Dev. Officer	Sell	2,887	$14.83	$42,817.67	-5.9%	-	-
Feb 11, 2021	Shah Jatin54	EVP, Chief Medical Officer	Sale+OE	1,748	$15.52	$27,127.39	-3.5%	-	-
Feb 11, 2021	Frenkel Ran78	EVP, Chief Dev. Officer	Sale+OE	2,046	$15.52	$31,751.87	-4.9%	-	-
Feb 11, 2021	Shacham Sharon79	President &CSO	Sale+OE	13,243	$15.52	$205,518.12	-1.0%	-	-
Feb 11, 2021	Kauffman Michael78	Chief Executive Officer	Sale+OE	13,243	$15.52	$205,518.12	-1.0%	-	-

← PrevPage 12Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC